Oncimmune Holdings (GB:ONC) has released an update.
Oncimmune Holdings has successfully raised approximately £2.3 million following the approval of resolutions at a recent General Meeting. The company has initiated the trading of additional ordinary shares on AIM, increasing its total shares in issue to over 111 million. This strategic move aims to bolster Oncimmune’s financial standing and support its efforts in precision medicine research.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount Global (NASDAQ:PARA) Adds an Ad-Supported Tier in Europe
- How Ford (NYSE:F) Looks to Solve Its Hydrogen Engine Problem
- The Intel (NASDAQ:INTC) “Coffee Debacle” Is Now Solved
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
